JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹23 Cr | ₹19 Cr | ₹16 Cr | ₹16 Cr | ₹21 Cr |
What is the latest Total Current Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹23 Cr |
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹16 Cr |
| Mar2023 | ₹16 Cr |
| Mar2022 | ₹21 Cr |
How is Total Current Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹23 Cr | 23.00 | |
| Mar2025 | ₹19 Cr | 14.90 | |
| Mar2024 | ₹16 Cr | 3.91 | |
| Mar2023 | ₹16 Cr | -25.93 | |
| Mar2022 | ₹21 Cr | - | |
Compare Total Current Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹402.6 Cr | -3.2% | -9.1% | -12.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,620.0 Cr | -0.2% | -5.1% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,714.0 Cr | -3.8% | -3.2% | 51.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,741.0 Cr | -1.7% | -7.7% | 29.9% | Stock Analytics | |
| CIPLA | ₹106,061.0 Cr | 0.6% | -3.8% | -11% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,339.0 Cr | 2.9% | 4.6% | 0.4% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -3.2% |
-9.1% |
-12.6% |
| SENSEX | 0.2% |
-2.8% |
-11.2% |
You may also like the below Video Courses